Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: Relevance for drug delivery systems

European Journal of Cell Biology

Volumn 93, Issue 8-9, 2014, Pages 323-337

  Firdessa, Rebuma ^a   Oelschlaeger, Tobias A ^a   Moll, Heidrun ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Endocytosis; Factor determining uptake; Multiple uptake; Nanoparticle; Ultrastructure

Indexed keywords

NANOPARTICLE; POLYSTYRENE;

ACIDITY; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL INTERACTION; CELL MEMBRANE; CELL ORGANELLE; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENERGY; HUMAN; HUMAN CELL; INTERNALIZATION; L929 CELL LINE; MAMMAL CELL; MOUSE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

MAMMALIA;

EID: 84939252601     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2014.08.001     Document Type: Article

References (62)

1. Albanese A., Tang P.S., Chan W.C.W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14:1-16. 10.1146/annurev-bioeng-071811-150124.
2. Albanese A., Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 2014, 8:5515-5526. 10.1021/nn4061012.
3. 2 particles in HeLa cells. Arch. Toxicol. 2011, 85:813-826. 10.1007/s00204-010-0642-5.
4. Basu N., Sett R., Das P.K. Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani. Biochem. J. 1991, 277:451-456.
5. Briones E., Colino C.I., Lanao J.M. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J. Control. Release 2008, 125:210-227. 10.1016/j.jconrel.2007.10.027.
6. Chou L.Y.T., Ming K., Chan W.C.W. Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev. 2011, 40:233-245. 10.1039/c0cs00003e.
7. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44. 10.1038/nature01451.
8. Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv. Drug Deliv. Rev. 2013, 65:21-23. 10.1016/j.addr.2012.04.010.
9. Dogra N., Warburton C., McMaster W.R. Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective. Infect. Immun. 2007, 75:3506-3515. 10.1128/IAI.00277-07.
10. Dos Santos T., Varela J., Lynch I., Salvati A., Dawson K.A. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small 2011, 7:3341-3349. 10.1002/smll.201101076.
11. Fernando L.P., Kandel P.K., Yu J., McNeill J., Ackroyd P.C., Christensen K.a. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules 2010, 11:2675-2682. 10.1021/bm1007103.
12. Gregory D.J., Sladek R., Olivier M., Matlashewski G. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect. Immun. 2008, 76:1186-1192. 10.1128/IAI.01320-07.
13. Gupta S., Sane S.A., Shakya N., Vishwakarma P., Haq W. CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis. Antimicrob. Agents Chemother. 2011, 55:3461-3464. 10.1128/AAC.00137-11.
14. Hansen C.G., Nichols B.J. Molecular mechanisms of clathrin-independent endocytosis. J. Cell Sci. 2009, 122:1713-1721. 10.1242/jcs.033951.
15. Herd H., Daum N., Jones A.T., Huwer H., Ghandehari H., Lehr C.-M. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 2013, 7:1961-1973. 10.1021/nn304439f.
16. Hu Y., Xie J., Tong Y.W., Wang C.-H. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J. Control. Release 2007, 118:7-17. 10.1016/j.jconrel.2006.11.028.
17. Iversen T.-G., Skotland T., Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011, 6:176-185. 10.1016/j.nantod.2011.02.003.
18. Jambo K.C., Banda D.H., Kankwatira A.M., Sukumar N., Allain T.J., Heyderman R.S., Russell D.G., Mwandumba H.C. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol. 2014, 10.1038/mi.2013.127.
19. Kang B., Yu D.-C., Chang S.-Q., Chen D., Dai Y.-D., Ding Y. Intracellular uptake, trafficking and subcellular distribution of folate conjugated single walled carbon nanotubes within living cells. Nanotechnology 2008, 19:375103. 10.1088/0957-4484/19/37/375103.
20. Karve S., Werner M.E., Sukumar R., Cummings N.D., Copp J.A., Wang E.C., Li C., Sethi M., Chen R.C., Pacold M.E., Wang A.Z. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:8230-8235. 10.1073/pnas.1120508109.
21. Karlson T.D.L., Kong Y.Y., Hardy C.L., Xiang S.D., Plebanski M. The signalling imprints of nanoparticle uptake by bone marrow derived dendritic cells. Methods 2013, 60:275-283. 10.1016/j.ymeth.2013.02.00.
22. Kastl L., Sasse D., Wulf V., Hartmann R., Mircheski J., Ranke C., Carregal-Romero S., Martínez-López J.A., Fernández-Chacón R., Parak W.J., Elsasser H.-P., Rivera Gil P. Multiple internalization pathways of polyelectrolyte multilayer capsules into mammalian cells. ACS Nano 2013, 7:6605-66018. 10.1021/nn306032k.
23. Kettler K., Veltman K., van de Meent D., van Wezel A., Hendriks A.J. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ. Toxicol. Chem./SETAC 2014, 33(3):481-492. 10.1002/etc.2470.
24. Khalil I.A., Kogure K., Akita H., Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharm. Res. 2006, 58:32-45. 10.1124/pr.58.1.8.
25. Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanomedicine. N. Engl. J. Med. 2010, 363:2434-2443. 10.1056/NEJMra0912273.
26. Kim J.A., Åberg C., Salvati A., Dawson K.A. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat. Nanotechnol. 2012, 7:62-68. 10.1038/nnano.2011.191.
27. Kirchhausen T., Macia E., Pelish H.E. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol. 2008, 438:77-93. 10.1016/S0076-6879(07)38006-3.
28. Kulkarni S.A., Feng S.-S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 2013, 30:2512-2522. 10.1007/s11095-012-0958-3.
29. Kumari S., Mg S., Mayor S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 2010, 20:256-275. 10.1038/cr.2010.19.
30. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 2005, 6:112-126. 10.1038/nrm1571.
31. Lemaire J., Mkannez G., Guerfali F.Z., Gustin C., Attia H., Sghaier R.M., Dellagi K., Laouini D., Renard P. MicroRNA expression profile in human macrophages in response to Leishmania major infection. PLoS Negl. Trop. Dis 2013, 7:e2478. 10.1371/journal.pntd.0002478.
32. Li H., Li Y., Jiao J., Hu H.-M. Alpha-alumina nanoparticles induce efficient autophagy dependent cross-presentation and potent antitumour response. Nat. Nanotechnol. 2011, 6:645-650. 10.1038/nnano.2011.153.
33. Li K., Schneider M. Quantitative evaluation and visualization of size effect on cellular uptake of gold nanoparticles by multiphoton imaging-UV/Vis spectroscopic analysis. J. Biomed. Opt. 2014, 19:101505. 10.1117/1.JBO.19.10.101505.
34. Liu H., Chen S., Zhou Y., Che X., Bao Z., Li S., Xu J. The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution. J. Drug Target 2013, 21:846-854. 10.3109/1061186X.2013.829075.
35. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533. 10.1038/nrm3151.
36. Moscatelli A., Ciampolini F., Rodighiero S., Onelli E., Cresti M., Santo N., Idilli A. Distinct endocytic pathways identified in tobacco pollen tubes using charged nanogold. J. Cell Sci. 2007, 120:3804-3819. 10.1242/jcs.012138.
37. Mu Q., Hondow N.S., Krzemiński L., Brown A.P., Jeuken L.J.C., Routledge M.N. Mechanism of cellular uptake of genotoxic silica nanoparticles. Part. Fibre Toxicol. 2012, 9:29. 10.1186/1743-8977-9-29.
38. Nagahama M., Itohayashi Y., Hara H., Higashihara M., Fukatani Y., Takagishi T., Oda M., Kobayashi K., Nakagawa I., Sakurai J. Cellular vacuolation induced by Clostridium perfringens epsilon-toxin. FASEB J. 2011, 278:3395-3407. 10.1111/j.1742-4658.2011.08263.x.
39. Olivier M., Gregory D.J., Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 2005, 18:293-305. 10.1128/CMR.18.2.293-305.2005.
40. Olsson A. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J. Biol. Chem. 1995, 270:28425-28432. 10.1074/jbc.270.47.28425.
41. Park M.C., Kim D., Lee Y., Kwon H.-J. CD83 expression induced by CpG-DNA stimulation in a macrophage cell line RAW 264.7. BMB Rep. 2013, 46:448-453.
42. Ponte-Sucre A., Gulder T., Wegehaupt A., Albert C., Rikanović C., Schaeflein L., . . . Frank A., Schultheis M., Unger M., Holzgrabe U., Bringmann G., Moll H. Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N, C-coupled arylisoquinolinium salts. J. Med. Chem. 2009, 52:626-636. 10.1021/jm801084u.
43. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377:159-169. 10.1042/BJ2003125.
44. Roth M.G. Integrating actin assembly and endocytosis. Dev. Cell 2007, 13:3-4. 10.1016/j.devcel.2007.06.005.
45. Saha K., Kim S.T., Yan B., Miranda O.R., Alfonso F.S., Shlosman D., Rotello V.M. Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells. Small 2013, 9:300-305. 10.1002/smll.201201129.
46. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J. Control. Release 2010, 145:182-195. 10.1016/j.jconrel.2010.01.036.
47. Salvati A., Aberg C., dos Santos T., Varela J., Pinto P., Lynch I., Dawson K.A. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine 2011, 7:818-826. 10.1016/j.nano.2011.03.005.
48. Sandvig K., Pust S., Skotland T., van Deurs B. Clathrin-independent endocytosis: mechanisms and function. Curr. Opin. Cell Biol. 2011, 23:413-420. 10.1016/j.ceb.2011.03.007.
49. Sanjuan M.A., Dillon C.P., Tait S.W.G., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., Green D.R. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257. 10.1038/nature06421.
50. Sato K., Nagai J., Mitsui N., Ryoko Yumoto, Takano M. Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells. Life Sci. 2009, 85:800-807. 10.1016/j.lfs.2009.10.012.
51. Scita G., Di Fiore P.P. The endocytic matrix. Nature 2010, 463:464-473. 10.1038/nature08910.
52. Shima F., Uto T., Akagi T., Baba M., Akashi M. Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. Acta Biomater 2013, 9:8894-8901. 10.1016/j.actbio.2013.06.010.
53. Smith D.M., Simon J.K., Baker J.R. Applications of nanotechnology for immunology. Nat. Rev. Immunol. 2013, 13:592-605. 10.1038/nri3488.
54. Steigerwald M., Moll H. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect. Immun. 2005, 73:2564-2567. 10.1128/IAI.73.4.2564-2567.2005.
55. Underhill D.M., Goodridge H.S. Information processing during phagocytosis. Nat. Rev. Immunol. 2012, 12:492-502. 10.1038/nri3244.
56. Utaisincharoen P., Kespichayawattana W., Anuntagool N., Chaisuriya P., Pichyangkul S., Krieg a.M., Sirisinha S. CpG ODN enhances uptake of bacteria by mouse macrophages. Clin. Exp. Immunol. 2003, 132:70-75.
57. Vercauteren D., Vandenbroucke R.E., Jones A.T., Rejman J., Demeester J., De Smedt S.C., Sanders N.N., Braeckmans K. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol. Ther. 2010, 18:561-569. 10.1038/mt.2009.281.
58. Wang A.Z., Langer R., Farokhzad O.C. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 2012, 63:185-198. 10.1146/annurev-med-040210-162544.
59. Wang J., Huang W.-L., Liu R.-Y. CpG-ODN enhances ingestion of apoptotic neutrophils by macrophages. Clin. Exp. Med. 2009, 9:37-43. 10.1007/s10238-008-0017-x.
60. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2:85-96. 10.1021/nn700256c.
61. Xu S., Olenyuk B.Z., Okamoto C.T., Hamm-Alvarez S.F. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Deliv. Rev 2013, 65:121-138. 10.1016/j.addr.2012.09.041.
62. Yan Y., Such G.K., Johnston A.P.R., Best J.P., Caruso F. Engineering particles for therapeutic delivery: prospects and challenges. ACS Nano 2012, 6:3663-3669. 10.1021/nn3016162.